GINGER by Evolva

Current Status
COMING TO MARKET
Company
Further Notes
Evolva’s development of vanillin and resveratrol will pave the way to the commercialisation of a number of other ingredients that derive from the same metabolic pathway. Total sales of such ingredients are estimated to amount to several hundred millions of dollars per annum and include additional vanilla flavour compounds as well as ingredients with completely different properties (for example the active principles of turmeric and ginger, as well as certain high intensity sweeteners and pharmaceutical active ingredients or intermediates - See more at: http://www.evolva.com/press-release/evolva-acquires-resveratrol-programme-from-fluxome/#sthash.al6Mp5Rj.dpuf
Compound